Abstract
In this issue, APBN looks into new developments happening within the field of oncology and considers how biotechnology is paving the way for more effective cancer treatments. Firstly, we have Dr Kim Strydom and Dr Edwin Gumafelix of IQVIA to share about CAR-T cell therapy and how we can optimise its clinical trial process to benefit a larger group of patients. Then, Vishal Doshi of AUM Biosciences looks into the potential of biotechnology in transforming cancer therapeutics and how precision medicine can bridge the gaps in cancer care. In Spotlights, we spoke to Dr Lim Hwee Yong, Specialist Medical Oncologist at the Novena Cancer Centre about lung cancer and how the drug Rybrevant presents a hope for patients with a rare type of lung cancer. Finally, in Columns, Dr Varun Sethi of DKSH Business Unit Healthcare describes some of the key trends in Asia-Pacific's healthcare ecosystem and what we can expect to see this year.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
